Pellock JM - Search Results

1

The accuracy of self-reported history of seizures in Danish, Norwegian and U.S. twins.

Corey LA, Kjeldsen MJ, Solaas MH, Nakken KO, Friis ML, Pellock JM. Corey LA, et al. Among authors: pellock jm. Epilepsy Res. 2009 Mar;84(1):1-5. doi: 10.1016/j.eplepsyres.2008.11.014. Epub 2009 Jan 6. Epilepsy Res. 2009. PMID: 19128944 Free PMC article.

2

Epilepsy After Febrile Seizures: Twins Suggest Genetic Influence.

Seinfeld SA, Pellock JM, Kjeldsen MJ, Nakken KO, Corey LA. Seinfeld SA, et al. Among authors: pellock jm. Pediatr Neurol. 2016 Feb;55:14-6. doi: 10.1016/j.pediatrneurol.2015.10.008. Epub 2015 Oct 31. Pediatr Neurol. 2016. PMID: 26638777 Free PMC article.

3

Importance of genetic factors in the occurrence of epilepsy syndrome type: a twin study.

Corey LA, Pellock JM, Kjeldsen MJ, Nakken KO. Corey LA, et al. Among authors: pellock jm. Epilepsy Res. 2011 Nov;97(1-2):103-11. doi: 10.1016/j.eplepsyres.2011.07.018. Epub 2011 Aug 31. Epilepsy Res. 2011. PMID: 21885256 Free PMC article.

4

Zonisamide: physician and patient experiences.

Marmarou A, Pellock JM. Marmarou A, et al. Among authors: pellock jm. Epilepsy Res. 2005 Mar-Apr;64(1-2):63-9. doi: 10.1016/j.eplepsyres.2005.03.001. Epilepsy Res. 2005. PMID: 15869867 Clinical Trial.

5

Felbamate: consensus of current clinical experience.

Pellock JM, Faught E, Leppik IE, Shinnar S, Zupanc ML. Pellock JM, et al. Epilepsy Res. 2006 Oct;71(2-3):89-101. doi: 10.1016/j.eplepsyres.2006.06.020. Epub 2006 Aug 4. Epilepsy Res. 2006. PMID: 16889941 Review.

6

Prevalence of pediatric epilepsy in low-income rural Midwestern counties.

Hawley SR, Ablah E, Hesdorffer D, Pellock JM, Lindeman DP, Paschal AM, Thurman DJ, Liu Y, Warren MB, Schmitz T, Rogers A, St Romain T, Hauser WA; Prevalence of Epilepsy in Rural Kansas Study Group. Hawley SR, et al. Among authors: pellock jm. Epilepsy Behav. 2015 Dec;53:190-6. doi: 10.1016/j.yebeh.2015.09.014. Epub 2015 Nov 14. Epilepsy Behav. 2015. PMID: 26588587

7

Is there a need for further trials for the treatment of prolonged seizures?

Pellock JM, Seinfeld S. Pellock JM, et al. Epileptic Disord. 2014 Oct;16 Spec No 1:S103-7. doi: 10.1684/epd.2014.0693. Epileptic Disord. 2014. PMID: 25323680 Review.

8

Registry initiated to characterize vision loss associated with vigabatrin therapy.

Pellock JM, Faught E, Sergott RC, Shields WD, Burkhart GA, Krauss GL, Foroozan R, Wesche DL, Weinberg MA. Pellock JM, et al. Epilepsy Behav. 2011 Dec;22(4):710-7. doi: 10.1016/j.yebeh.2011.08.034. Epub 2011 Oct 5. Epilepsy Behav. 2011. PMID: 21978471

9

Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy.

Pellock JM, Smith MC, Cloyd JC, Uthman B, Wilder BJ. Pellock JM, et al. Epilepsy Behav. 2004 Jun;5(3):301-7. doi: 10.1016/j.yebeh.2004.01.009. Epilepsy Behav. 2004. PMID: 15145298 Review.

10

Sabril® registry 5-year results: Characteristics of adult patients treated with vigabatrin.

Krauss G, Faught E, Foroozan R, Pellock JM, Sergott RC, Shields WD, Ziemann A, Dribinsky Y, Lee D, Torri S, Othman F, Isojarvi J. Krauss G, et al. Among authors: pellock jm. Epilepsy Behav. 2016 Mar;56:15-9. doi: 10.1016/j.yebeh.2015.12.004. Epub 2016 Jan 22. Epilepsy Behav. 2016. PMID: 26807550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page